333 related articles for article (PubMed ID: 16519795)
1. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.
Montesinos MC; Desai A; Cronstein BN
Arthritis Res Ther; 2006; 8(2):R53. PubMed ID: 16519795
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.
Montesinos MC; Desai A; Delano D; Chen JF; Fink JS; Jacobson MA; Cronstein BN
Arthritis Rheum; 2003 Jan; 48(1):240-7. PubMed ID: 12528125
[TBL] [Abstract][Full Text] [Related]
3. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
4. Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.
Delano DL; Montesinos MC; Desai A; Wilder T; Fernandez P; D'Eustachio P; Wiltshire T; Cronstein BN
Arthritis Rheum; 2005 Aug; 52(8):2567-75. PubMed ID: 16059892
[TBL] [Abstract][Full Text] [Related]
5. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
6. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
[TBL] [Abstract][Full Text] [Related]
7. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis.
Montesinos MC; Yap JS; Desai A; Posadas I; McCrary CT; Cronstein BN
Arthritis Rheum; 2000 Mar; 43(3):656-63. PubMed ID: 10728760
[TBL] [Abstract][Full Text] [Related]
8. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
9. Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.
Belikoff B; Hatfield S; Sitkovsky M; Remick DG
Shock; 2011 Apr; 35(4):382-7. PubMed ID: 21192284
[TBL] [Abstract][Full Text] [Related]
10. Role and Function of A
Ravani A; Vincenzi F; Bortoluzzi A; Padovan M; Pasquini S; Gessi S; Merighi S; Borea PA; Govoni M; Varani K
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338619
[TBL] [Abstract][Full Text] [Related]
11. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.
Cronstein BN; Naime D; Ostad E
J Clin Invest; 1993 Dec; 92(6):2675-82. PubMed ID: 8254024
[TBL] [Abstract][Full Text] [Related]
12. The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
Antonioli L; Fornai M; Colucci R; Awwad O; Ghisu N; Tuccori M; Da Settimo F; La Motta C; Natale G; Duranti E; Virdis A; Blandizzi C
J Pharmacol Exp Ther; 2010 Nov; 335(2):434-42. PubMed ID: 20668053
[TBL] [Abstract][Full Text] [Related]
13. A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts.
Zhou X; Teng B; Tilley S; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1668-79. PubMed ID: 24043252
[TBL] [Abstract][Full Text] [Related]
14. Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice.
Arasa J; Martos P; Terencio MC; Valcuende-Cavero F; Montesinos MC
Exp Dermatol; 2014 Aug; 23(8):555-60. PubMed ID: 24889129
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
16. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
[TBL] [Abstract][Full Text] [Related]
17. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo.
Gomez G; Sitkovsky MV
Blood; 2003 Dec; 102(13):4472-8. PubMed ID: 12947007
[TBL] [Abstract][Full Text] [Related]
18. Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.
van der Hoeven D; Wan TC; Auchampach JA
Mol Pharmacol; 2008 Sep; 74(3):685-96. PubMed ID: 18583455
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: Methotrexate Prevents Wear Particle-Induced Inflammatory Osteolysis in Mice Via Activation of Adenosine A2A Receptor.
Mediero A; Perez-Aso M; Wilder T; Cronstein BN
Arthritis Rheumatol; 2015 Mar; 67(3):849-55. PubMed ID: 25533750
[TBL] [Abstract][Full Text] [Related]
20. Potential role of A2A adenosine receptor in traumatic optic neuropathy.
Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI
J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
